We spoke with Deputy Health Minister Maciej Miłkowski during the Economic Forum in Karpacz about the changes introduced in the treatment of rare diseases by the September list of reimbursed drugs, the work related to the November list, and the needs of patients with neurofibromatosis.
Maciej Miłkowski:
- In rare diseases, there are more and more narrow indications for specific genetic types.
- The November list ...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
